Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

58.89%

64.90%

58.50%

66.15%

Annual Dental Visits (ADV) Total

41.82%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

36.41%

46.74%

41.14%

48.16%

Appropriate Testing for Pharyngitis (CWP)

67.80%

77.56%

81.82%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

89.92%

93.08%

88.58%

91.27%

Asthma Medication Ratio (AMR) Total

58.23%

69.41%

58.73%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

56.96%

66.19%

52.81%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

63.99%

68.61%

70.32%

71.78%

Breast Cancer Screening (BCS)

46.73%

55.25%

Breast Cancer Screening (BCS-E)

46.60%

54.94%

47.85%

56.66%

Cervical Cancer Screening (CCS)

51.85%

59.85%

56.93%

60.10%

Childhood Immunization Status (CIS) Combination #10

30.90%

35.04%

28.47%

31.32%

Chlamydia Screening in Women (CHL) Total

64.63%

61.07%

58.20%

61.46%

Controlling High Blood Pressure (CBP)

55.72%

65.45%

60.69%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

76.33%

80.86%

78.01%

83.51%

Eye Exam for Patients With Diabetes (EED)

52.80%

56.20%

53.77%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

29.81%

27.73%

26.83%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

52.64%

46.35%

49.71%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

34.51%

41.03%

40.67%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

51.03%

37.31%

52.83%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

57.17%

57.90%

54.00%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

54.00%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

51.58%

55.72%

54.99%

59.64%

Immunizations for Adolescents (IMA) Combination #2

32.67%

38.93%

33.82%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

37.20%

16.94%

36.33%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

29.12%

38.80%

30.67%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

32.05%

39.01%

28.12%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

28.12%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

14.08%

31.93%

14.00%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

78.10%

75.79%

77.31%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

88.52%

86.96%

87.68%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

95.06%

≤ 92.72%

89.37%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

82.73%

86.86%

82.32%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

73.72%

80.78%

73.48%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

18.36%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

18.36%

25.81%

17.63%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

1.45%

≤ 2.45%

3.93%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

82.81%

81.64%

84.93%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

63.09%

73.63%

69.95%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

67.89%

67.07%

66.94%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

60.75%

70.37%

67.64%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

76.66%

63.89%

75.61%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

67.83%

75.44%

63.43%

72.74%

Use of Opioids at High Dosage (HDO)

2.21%

≤ 2.19%

2.86%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

1.43%

≤ 0.87%

1.08%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

74.94%

83.21%

75.91%

86.20%